CLOV vs TLSIW · rev $1.37B vs rev $29.4M
Clover Health Investments Corp (CLOV) versus TriSalus Life Sciences Inc. (TLSIW) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TriSalus Life Sciences Inc. (TLSIW) common stock listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TLSIW revenue for 2024-12-31 was $29.4M. Net income was -$30.0M. Revenue was up 59.0% from 2023-12-31 to 2024-12-31. TLSIW currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. TLSIW currently screens at market cap $0.
Not investment advice. Open the CLOV and TLSIW stock pages for the full models.
Not investment advice.